UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 162

Sortiert nach

Biomarker analysis in a phase III study of pemetrexed–carboplatin versus etoposide–carboplatin in chemonaive patients with extensive-stage small-cell lung cancer

Annals of oncology, 2012-07, Vol.23 (7), p.1723-1729

2012

Volltextzugriff (PDF)

Hyperhomocysteinemia and the Endocrine System: Implications for Atherosclerosis and Thrombosis

Endocrine reviews, 1999-10, Vol.20 (5), p.738-759

1999

Volltextzugriff (PDF)

Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients

Annals of oncology, 2016-08, Vol.27 (8), p.1612-1619

2016

Volltextzugriff (PDF)

Hyperhomocysteinemia : An emerging and important risk factor for thromboembolic and cardiovascular disease

American journal of clinical pathology, 1996-12, Vol.106 (6), p.709-722

1996

Volltextzugriff (PDF)

Peripheral stem cell mobilization and engraftment in patients over age 60

Bone marrow transplantation (Basingstoke), 1997-07, Vol.20 (1), p.1-3

1997

Volltextzugriff (PDF)

Bone Marrow Stromal Fibroblasts Secrete Interleukin-6 and Granulocyte-Macrophage Colony-Stimulating Factor in the Absence of Inflammatory Stimulation: Demonstration by Serum-Free Bioassay, Enzyme-Linked Immunosorbent Assay, and Reverse Transcriptase Polymerase Chain Reaction

Blood, 1992-09, Vol.80 (5), p.1190-1198

1992

Volltextzugriff (PDF)

Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia

Blood, 1994-03, Vol.83 (6), p.1486-1492

1994

Volltextzugriff (PDF)

Regulation of interleukin 3 gene induction in normal human T cells

The Journal of clinical investigation, 1989-12, Vol.84 (6), p.1701-1706

1989

Volltextzugriff (PDF)

A phase 1b/2 dose escalation and cohort expansion study of the safety, tolerability and efficacy of a transforming growth factor-beta (TGF-&bgr;) receptor I kinase inhibitor (galunisertib) in combination with anti–PD-1 (nivolumab) in advanced refractory solid tumours

Annals of oncology, 2016-10, Vol.27, p.vi377-vi377

2016

Volltextzugriff (PDF)

Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway

Drug design, development and therapy, 2015-01, Vol.9 (default), p.4479-4499

2015

Volltextzugriff (PDF)

Hyperhomocysteinemia and premature vascular occlusive disease

The American journal of the medical sciences, 1998-04, Vol.315 (4), p.279-285

1998

Volltextzugriff (PDF)

Hyperhomocysteinemia and Thrombosis

Seminars in thrombosis and hemostasis, 1999-01, Vol.25 (3), p.291-309

1999

Volltextzugriff (PDF)

Hyperhomocysteinemia and thrombosis: Hereditary and Acquired Thrombophilia. Part I

Seminars in thrombosis and hemostasis, 1999, Vol.25 (3), p.291-309

1999

Volltextzugriff (PDF)

Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia

Blood, 1994-03, Vol.83 (6), p.1486-1492

1994

Volltextzugriff (PDF)

Bone marrow stromal fibroblasts secrete interleukin-6 and granulocyte- macrophage colony-stimulating factor in the absence of inflammatory stimulation: demonstration by serum-free bioassay, enzyme-linked immunosorbent assay, and reverse transcriptase polymerase chain reaction

Blood, 1992-09, Vol.80 (5), p.1190-1198

1992

Volltextzugriff (PDF)

Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e002068

2021

Volltextzugriff (PDF)

Convection‐Permitting Simulations With the E3SM Global Atmosphere Model

Journal of advances in modeling earth systems, 2021-11, Vol.13 (11), p.n/a

2021

Volltextzugriff (PDF)

A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer

BMC cancer, 2023-07, Vol.23 (1), p.708-708, Article 708

2023

Volltextzugriff (PDF)

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

Cell stem cell, 2007-09, Vol.1 (3), p.313-323

2007

Volltextzugriff (PDF)

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma

Neuro-oncology (Charlottesville, Va.), 2016-08, Vol.18 (8), p.1146-1156

2016

Volltextzugriff (PDF)

Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma

Investigational new drugs, 2020-10, Vol.38 (5), p.1570-1579

2020

Volltextzugriff (PDF)

Exploring the impact of a fraction sense intervention in authentic school environments: An initial investigation

Journal of experimental child psychology, 2024-08, Vol.244, p.105954, Article 105954

2024

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(130)

Publikationsform

Sprache

Englisch
(158)
Japanisch
(19)
Deutsch
(8)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(97)
Life Sciences & Biomedicine
(81)
Humans
(75)
Biological And Medical Sciences
(38)
Male
(34)
Medical Sciences
(31)
Oncology
(31)
Female
(28)
Animals
(25)
Adult
(21)
Middle Aged
(21)
Surgery
(18)
Aged
(17)
Treatment Outcome
(17)
Mice
(16)
Physical Sciences
(16)
Tumors
(15)
Transplantation
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Chemistry
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Biomarker analysis in a phase III study of pemetrexed–carboplatin versus etoposide–carboplatin in chemonaive patients with extensive-stage small-cell lung cancer

Hyperhomocysteinemia and the Endocrine System: Implications for Atherosclerosis and Thrombosis

Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients

Hyperhomocysteinemia : An emerging and important risk factor for thromboembolic and cardiovascular disease

Peripheral stem cell mobilization and engraftment in patients over age 60

Bone Marrow Stromal Fibroblasts Secrete Interleukin-6 and Granulocyte-Macrophage Colony-Stimulating Factor in the Absence of Inflammatory Stimulation: Demonstration by Serum-Free Bioassay, Enzyme-Linked Immunosorbent Assay, and Reverse Transcriptase Polymerase Chain Reaction

Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia

Regulation of interleukin 3 gene induction in normal human T cells

A phase 1b/2 dose escalation and cohort expansion study of the safety, tolerability and efficacy of a transforming growth factor-beta (TGF-&bgr;) receptor I kinase inhibitor (galunisertib) in combination with anti–PD-1 (nivolumab) in advanced refractory solid tumours

Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway

Hyperhomocysteinemia and premature vascular occlusive disease

Hyperhomocysteinemia and Thrombosis

Hyperhomocysteinemia and thrombosis: Hereditary and Acquired Thrombophilia. Part I

Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia

Bone marrow stromal fibroblasts secrete interleukin-6 and granulocyte- macrophage colony-stimulating factor in the absence of inflammatory stimulation: demonstration by serum-free bioassay, enzyme-linked immunosorbent assay, and reverse transcriptase polymerase chain reaction

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data

Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer

Convection‐Permitting Simulations With the E3SM Global Atmosphere Model

PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer

A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma

Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma

Exploring the impact of a fraction sense intervention in authentic school environments: An initial investigation

Suchergebnisse filtern